Systematic review and meta-analysis of the influence of prophylactic pyloric balloon dilatation in the prevention of early delayed gastric emptying after oesophagectomy

Dis Esophagus. 2022 Jun 15;35(6):doab062. doi: 10.1093/dote/doab062.

Abstract

Background: Early delayed gastric emptying (DGE) occurs in up to 50% of patients following oesophagectomy, which can contribute to increased anastomotic leak and respiratory infection rates. Although the treatment of DGE in the form of pyloric balloon dilatation (PBD) post-operatively is well established, there is no consensus on the optimal approach in the prevention of DGE. The aim of this review was to determine the efficacy of prophylactic PBD in the prevention of DGE following oesophagectomy.

Method: PubMed, MEDLINE and the Cochrane Library (January 1990 to April 2021) were searched for studies reporting the outcomes of prophylactic PBD in patients who underwent oesophagectomy. The primary outcome measure was the rate of DGE. Secondary outcome measures include anastomotic leak rate and length of hospital stay.

Results: Three studies with a total of 203 patients [mean age 63 (26-82) years, 162 males (79.8%)] were analyzed. PBD with a 20-mm balloon was performed in 165 patients (46 patients had PBD and botox therapy) compared with 38 patients who had either no intervention or botox alone (14 patients). The pooled rates of early DGE [16.27%, 95% CI (12.29-20.24) vs. 39.02% (38.87-39.17) (P < 0.001)] and anastomotic leak [8.55%, 95% CI (8.51-8.59) vs. 12.23% (12.16-12.31), P < 0.001] were significantly lower in the PBD group.

Conclusion: Prophylactic PBD with a 20-mm balloon significantly reduced the rates of early delayed gastric emptying and anastomotic leak following oesophagectomy.

Keywords: digestive surgery; endoscopy; oesophageal cancer; oesophagogastric surgery.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Anastomotic Leak / etiology
  • Anastomotic Leak / prevention & control
  • Botulinum Toxins, Type A*
  • Dilatation
  • Esophagectomy / adverse effects
  • Gastric Emptying
  • Gastroparesis* / etiology
  • Gastroparesis* / prevention & control
  • Humans
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control

Substances

  • Botulinum Toxins, Type A